China's OPPO Research Institute calls for innovative proposals on digital health

China-based company OPPO has announced the OPPO Research Institute Innovation Accelerator to empower technology professi...

May 10, 2022 | Tuesday | News
China-based startup InxMed raises $15 M to advance therapies for drug-resistant cancers

InxMed, a Chinese clinical-stage biotechnology company dedicated to developing innovative therapies targeting ...

May 9, 2022 | Monday | News
Orion partners with Jemincare for novel non-opioid drug candidate for pain treatment

Finland's Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclu...

May 6, 2022 | Friday | News
EyePoint Pharma with Betta Pharma lay focus on eye diseases across the globe

EyePoint Pharmaceuticals has announced the execution of a license agreement with Betta Pharmaceuticals to develop and co...

May 5, 2022 | Thursday | News
China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...

May 5, 2022 | Thursday | News
China holds significant dominance in Asia breast cancer screening market: Report

According to the ResearchAndMarkets.com recent report, Asia Breast Cancer Screening Market is expected to reach $16...

May 4, 2022 | Wednesday | News
Hong Kong links gut microbial enzymes with colon inflammation

A Hong Kong Baptist University (HKBU) collaborative research study has revealed that certain gut microbial enzymes media...

May 4, 2022 | Wednesday | News
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...

May 4, 2022 | Wednesday | News
China Mobile Hong Kong launches online medical app "Dr. HK"

China Mobile Hong Kong (CMHK) has announced the launch of "Dr. HK", an online doctor consultation and medical app p...

May 4, 2022 | Wednesday | News
Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China

Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...

May 3, 2022 | Tuesday | News
China-based Biocytogen enters into antibody agreement with Merck

China's Biocytogen Pharmaceuticals has entered into an evaluation and option agreement with Merck to grant them a sole l...

May 2, 2022 | Monday | News
China-based I-Mab appoints new COO and CMO

China's I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

April 29, 2022 | Friday | News
Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...

April 29, 2022 | Friday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News
China's Antengene looks to start phase I trial in Australia

China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...

April 27, 2022 | Wednesday | News
Lupin partners with Yabao Pharma for paediatric formulations in China

Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co, to meet the growing demand for ...

April 27, 2022 | Wednesday | News
China releases first international COVID-19 testing standard

According to the State Administration for Market Regulation in China, the International Organization for Standardization...

April 26, 2022 | Tuesday | News
Startups accelerate cell therapy development for solid tumours in China

China-based startups Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine have announced a long-term strateg...

April 25, 2022 | Monday | News